Literature DB >> 8629126

Prenatal diagnosis of Hb Bart's hydrops fetalis by PCR technique: Pramongkutklao experience.

K Torcharus1, T Sriphaisal, T Krutvecho, A Ketupanya, C Vuthiwong, C Suwanasophon, A Noonai.   

Abstract

Hb Bart's hydrops fetalis is very common in Southeast Asia, especially in Thailand. As the mother of such an infant may suffer from toxemia of pregnancy, ante- or post-partum hemorrhage as well as the psychological burden for carrying a nonviable fetus to term, so prenatal diagnosis is indicated and the family should be given the choice of early termination of the pregnancy. Seven high risk pregnancies with Hb Bart's hydrops fetalis (homozygous alpha-thalassemia 1) were studied. Amniocentesis was done at 16-33 weeks of gestation. DNA analysis was performed by polymerase chain reaction (PCR) using 2 techniques, 1) three nucleotide primers and 2) four nucleotide primers. After either therapeutic abortion or birth, heart blood or cord blood was drawn to confirm the diagnosis by Hb electrophoresis and DNA analysis. Of 7 high risk fetuses, 3 were recognized as Hb Bart's hydrops fetalis, 2 showed the alpha-thal 1 trait, 1 showed alpha-thal 2 trait and 1 was a normal fetus. The technique was entirely suitable for prenatal diagnosis of Hb Bart's hydrops fetalis. This technique was a rapid, simple non-radioactive method, less expensive and available in most PCR laboratories.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8629126

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Rapid diagnosis of alpha-thalassemia by melting curve analysis.

Authors:  Thongperm Munkongdee; Phantip Vattanaviboon; Parichut Thummarati; Paijit Sewamart; Pranee Winichagoon; Suthat Fucharoen; Saovaros Svasti
Journal:  J Mol Diagn       Date:  2010-02-26       Impact factor: 5.568

2.  Increased Prevalence of Thalassemia in Young People in Korea: Impact of Increasing Immigration.

Authors:  Hyun Ji Lee; Kyung Hwa Shin; Hyung Hoi Kim; Eu Jeen Yang; Kyung Hee Park; Min Ju Kim; Jeong Ran Kwon; Young Sil Choi; Jun Nyun Kim; Myung Geun Shin; Yong Gon Cho; Sun Jun Kim; Kyeong Hee Kim; Seri Jeong; Seom Gim Kong; Yu Jin Jung; Nayoung Lee; Man Jin Kim; Moon Woo Seong
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.